Jump to page content

The first tandems for the new funding line were selected in January 2025 and began their two-year funding period in spring 2025. The tandem partners come from Dresden, Erlangen, Hanover, Berlin, and Mainz and introduce themselves and their projects below.

Dr. med. Marie-Elisabeth Leßmann & Dr. rer. nat. Shady Sayed

 

 

GCT-Project:

Pioneering Molecular Surgery with CRISPR Technologies for Personalized Lung Cancer Therapy

More Information

Dr. med. Jan Beer & Dr. rer. nat. Tim Stüdemann

 

 

GCT-Project:

Nanoparticle mediated Cardiac Repair (NapaCaRe)

 

More Information

Dr. med. Tabaël Lee Turan & Dr. rer nat. Lucie Loyal

 

 

GCT-Project:

Optimized tumor therapy by integrating T cell receptor avidity analyses

 

More Information

Dr. med. Ben Ole Staar & Dr. rer. nat. Laura von Schledorn

 

 

GCT-Project:

Exploring the therapeutic potential of hiPSC-derived basal cells (iBCs) in the context of primary ciliary dyskinesia (PCD) utilizing an in vitro cell therapy model

 

More Information

Dr. Maria Hastermann & Dr. rer. nat. Nadine Strempel

 

 

GCT-Project:

Curative approaches for autoimmune diseases with tolerizing cellular therapy

 

More Information

Dr. med. Jan Lennart Stalp & Dr. rer. nat. Ivana Kutle

 

 

GCT-Project:

Harnessing primary gynecological cancer samples to identify new tumor antigens for next-generation cell therapies

More Information

Dr. Dr. med. Julien Subburayalu & Dr. rer. nat. Sethuraman Subramanian

 

 

GCT-Project:

Investigating cytokines as biomarkers for macrophage therapy of advanced lung cancer

More Information

Dr. med. Sebastian Schramm & Dr. rer. nat. Tanja Müller

 

 

GCT-Project:

Engineered ex vivo expanded regulatory T cells for autologous adoptive transfer therapy of ulcerative colitis

More Information

Dr. med. Sarah Dinges & Dr. rer. nat. Christopher Kreßler

 

 

GCT-Project:

Combining novel in vitro T cell differentiation systems for improved SCID diagnosis and for T cell product generation

More Information